Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration

Overview of attention for article published in Clinical Ophthalmology, February 2011

Altmetric Badge

Mentioned by

peer_reviews: 1 peer review site

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 22 Mendeley

Summary Peer reviews Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Vascular Endothelial Growth Factor Receptor 1 Facilitates the Effect of Macrophages on Human Umbilical Vein Endothelial Cells Migration by Regulating the M1 Polarization

Article in Journal of Biomedical Nanotechnology (December 2022)

Efficacy and safety of brolucizumab for serous drusenoid pigment epithelium detachment non-responder to bevacizumab and aflibercept

Article in European Journal of Ophthalmology (November 2022)

Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration: 24-month outcomes

Article in Graefe's Archive for Clinical and Experimental Ophthalmology (March 2022)